This page is in Beta testing. We welcome your feedback and suggestions as we look to improve this page.
Latest news
Stay informed on our major announcements through our media releases and other updates.
-
-
-
News articles
Read our latest news on regulatory decisions and activities, including product safety and enforcement actions. -
-
Safety updates
Refer to our articles for health professionals about health products and emerging safety issues. -
Health product safety alerts and market actions
See the latest alerts for consumers and health professionals about safety and quality issues with health products.
-
Safety alerts
Refer to the latest safety alerts for medicines or medical devices with possible risks. -
Events and consultations
Have your say on therapeutic goods regulation by participating in our public consultations or browse closed consultations. We also deliver a range of webinars, workshops and meetings on areas of interest for industry, consumers, and health professionals.
-
Consultations
Search open and closed consultations on the way we regulate medicines, medical devices and biologicals. -
Events
Search our upcoming and past events including webinars, committee meetings, presentations, and workshops.
Our subscription services
Stay connected and sign up to our RSS news feeds and email subscription services to receive real-time updates on our latest news, product shortage alerts, and media releases as we publish them, or subscribe to monthly updates.
-
Email subscriptions
We offer several email subscription options to keep you up to date with news and alerts. -
RSS feeds
RSS feeds (Really Simple Syndication feed) for immediate notifications of updates to the TGA website.
Industry notices and compliance undertakings
Notifications for sponsors, manufacturers, and advertisers about official decisions and new or updated regulatory requirements, as well as information about recent regulatory compliance and enforcement actions.
-
Regulatory decision notices
Access official regulatory decisions for sponsors, manufacturers and advertisers, including GMP clearances, listing notices, administrative instruments, and updates to regulatory requirements. -
Latest articles
-
Concerns regarding the public health risks associated with unapproved peptide products
Media releasesAustralia’s health leaders are increasingly concerned about the growing availability, promotion and use of unapproved peptide products in Australia. -
TGA releases new guidance on advertising restrictions for prescription medicines
Media releasesWe have published new guidance on advertising restrictions for prescription medicines. This is to help individuals and businesses comply with Australia’s regulatory requirements. -
TGA issues infringement notices to a health professional and an individual for alleged unlawful importation of cosmetic injectables
Media releasesWe have issued 5 infringement notices totalling $19,800 to a health practitioner and an individual for the alleged unlawful importation of unapproved cosmetic injectables.
Latest publications
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 26 March 2026
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsThe Advisory Committee on Medical Devices (ACMD) held its 90th meeting on 16 April 2026.
Latest consultations
-
ConsultationWe are seeking feedback on proposed changes to publishing information about Good Manufacturing Practice (GMP) compliance on our website.
-
ConsultationHave your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the Advisory Committee on Medicines Scheduling (ACMS), Advisory Committee on Chemicals Scheduling (ACCS), and the joint meeting of the ACMS and ACCS.
-
ConsultationWe are seeking feedback on proposed changes to improve the regulation of therapeutic sunscreens in Australia.